Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.55 |
| ▸ | CYP11B2 | P19099 | 18/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 17/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22225479 | 0.92 | TRPV4 (0.48) | TRPV4CYP11B2CYP11B1 | |
| SCHEMBL9293782 | 0.91 | CYP11B1 (0.50) | TRPV4CYP11B2CYP11B1 | |
| SCHEMBL6864959 | 0.91 | TRPV4 (0.47) | TRPV4CYP11B2CYP11B1 | |
| SCHEMBL1797379 | 0.86 | TRPV4 (0.59) | TRPV4CYP11B2CYP11B1 | |
| SCHEMBL13657794 | 0.86 | CYP11B1 (0.53) | TRPV4CYP11B2CYP11B1 | |
| SCHEMBL9293042 | 0.86 | CYP2A6 (0.52) | TRPV4CYP11B2CYP11B1 | |
| SCHEMBL9610046 | 0.85 | TRPV4 (0.42) | TRPV4CYP11B2CYP11B1 | |
| SCHEMBL8645459 | 0.84 | ACACB (0.45) | TRPV4CYP11B2CYP11B1 | |
| SCHEMBL23335104 | 0.83 | CYP11B1 (0.45) | TRPV4CYP11B2CYP11B1 | |
| SCHEMBL7851781 | 0.83 | TRPV4 (0.45) | TRPV4CYP11B2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9169208-B2 | Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-10-27 | — | — | US | disclosed |
| US-20120135249-A1 | AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135249-A1 | AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES | AHR, TYR, ARNT | TRPV4 67/4885CYP11B2 466/4885CYP11B1 622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.